A study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells ...

The approval is based on overall response rates from the Phase II eNRGy study, which enrolled advanced, previously treated NRG1 fusion-positive patients.

Sum 41 have had an unfortunate non-starter to their final Australian tour, being forced to cancel the first night at Brisbane ...

Computational biologists from the National University of Singapore (NUS) have uncovered how RNA splicing—a crucial process ...

New research reveals the heart has its own complex nervous system, or "mini-brain," capable of regulating the heartbeat independently of the brain.

4′-Fluorouridine works against RNA-dependent RNA polymerase, an enzyme that helps viruses assemble RNA. The compound has a ...

Theratechnologies gains exclusive rights to two investigational RNA-targeted medicines from Ionis Pharmaceuticals, olezarsen ...

Monte Rosa Therapeutics stock surged after a recent partnership with Novartis, despite limited clinical results. Can the ...

Get the last 2 weeks biotech industry news in this quick roundup of the last fortnight's products, people and partnerships ...

Dominique Verhelle is co-founder and CEO of the Brighton-based company NextRNA Therapeutics, which uses long non-coding RNA ...